Merck's Durham plant tagged for job growth

Merck has been steadily adding to its vaccine manufacturing plant in Durham, NC, and now says that it plans to hire up to 310 new workers there over the next two years. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

Amarin had big plans for Vascepa after a big label expansion last year, but it lost a patent fight—and now a generic has won FDA approval.

Intercept Pharmaceuticals, eager to market its potential nonalcoholic steatohepatitis medicine obeticholic acid, will have to keep waiting.